Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The revision label now reads v3.6.3 where it previously showed v3.6.2. This update reflects a small metadata version change and does not modify the study details.
    Difference
    0.0%
    Check dated 2026-07-04T13:35:46.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    New revision tag v3.6.2 has been added, replacing the previous v3.6.0. This reflects a minor update to the page’s underlying documentation/software version without changing the study content or how the page functions.
    Difference
    0.0%
    Check dated 2026-06-27T07:46:56.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The study page now states that recruitment has ended and includes new sections to help readers understand and join the study. The Intervention/Treatment heading has been standardized.
    Difference
    0.3%
    Check dated 2026-06-13T05:20:55.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a newer build of the page content.
    Difference
    0.0%
    Check dated 2026-06-05T22:15:28.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4, replacing the previous v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-15T14:50:54.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page’s software/version indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**. This reflects a site revision marker rather than a change to the clinical trial’s study information.
    Difference
    0.0%
    Check dated 2026-04-24T05:44:09.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.